Arrowhead Pharmaceuticals, Inc.
ALPHA-V BETA-6 INTEGRIN LIGANDS AND USES THEREOF
Last updated:
Abstract:
Integrin ligands having serum stability and affinity for .alpha.v.beta.6 integrins are described. Compositions comprising .alpha.v.beta.6 integrin ligands having serum stability and having affinity for .alpha.v.beta.6 integrins and methods of using them are also described.
Status:
Application
Type:
Utility
Filling date:
14 Oct 2021
Issue date:
27 Jan 2022